Cipla wants Ugandan firm to make its AIDS drug; WHO approves site
This article was originally published in Scrip
Executive Summary
The World Health Organization's prequalification programme says the facilities of Ugandan firm Quality Chemical Industries Ltd (QCIL) comply with its good manufacturing practice (GMP) requirements, after Indian generics firm Cipla requested the inspection, as part of a variation application, as it hopes to manufacture one of its pre-qualified antiretrovirals there.